Showing results (171-180 of 737) with videos related to
Sort By:
Pageof 74
Journal of Blood Medicine|November 17, 2025
Distribution and Genetic Characterization of the MNS Blood Group in Multi-Ethnic Populations of East ChinaZihao Xu, Zhihong Fang, Rong Lu, et al.Journal of Blood Medicine|October 8, 2025
Safety of Recombinant von Willebrand Factor in the Treatment of von Willebrand Disease: Real-World Data from an EU Post-Authorization Safety StudySusan M Sinclair, Yi Ba, Kayode BadejoJournal of Blood Medicine|October 14, 2025
Baseline CD4+/CD8+ TEMRA Levels and Early Response Predict Survival After Umbilical Cord-Derived Mesenchymal Stem Cells Infusion in Acute GVHD Patients: A Randomized Double-Blinded Placebo-Controlled Multicentre Clinical TrialSze-Piaw Chin, Sen Mui Tan, Kian Meng Chang, et al.Journal of Blood Medicine|December 28, 2020
D-Dimer Level Associates with the Incidence of Focal Neurological Deficits in Cerebral Venous Thrombosis PatientsCep Juli, Lisda Amalia, Uni Gamayani, et al.Journal of Blood Medicine|December 28, 2020
The Need for Comprehensive Care for Persons with Chronic Immune Thrombocytopenic PurpuraKristin T Ansteatt, Chanel J Unzicker, Marsha L Hurn, et al.Journal of Blood Medicine|December 30, 2020
Hematological Abnormalities and Associated Factors Among Undernourished Under-Five Children Attending University of Gondar Specialized Referral Hospital, Northwest EthiopiaSolomon Getawa, Zegeye Getaneh, Mulugeta MelkuJournal of Blood Medicine|December 19, 2019
Post-Transfusion Purpura: Current PerspectivesJaleah Hawkins, Richard H Aster, Brian R CurtisJournal of Blood Medicine|November 23, 2022
Impact of Abnormal Leukocyte Count in the Pathophysiology of Sickle Cell AnemiaTagwa Yousif Elsayed YousifJournal of Blood Medicine|March 27, 2020
Correlation of Cardiac and Liver Iron Level with T2*MRI and Vitamin D3 Serum Level in Patients with Thalassemia MajorRoya Shaykhbaygloo, Alireza Moradabadi, Hassan Taherahmadi, et al.Journal of Blood Medicine|October 29, 2020
An Open-Label Extension Study to Assess the Long-Term Efficacy and Safety of a Plasma-Derived von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Patients with von Willebrand Disease (SWIFT-VWDext Study)Toshko Lissitchkov, Anna Klukowska, Evgeny Buevich, et al.Pageof 74